Navigation Links
Simbionix Releases Two New Simulation Modules
Date:1/27/2009

CLEVELAND, Ohio, January 27 /PRNewswire/ -- Simbionix, the world's leading developer of medical simulation systems, has released two new endovascular training modules, Cerebral Interventions and Cardiac Rhythm Management.

These new ANGIO Mentor modules demonstrate Simbionix's commitment to enriching the content of its training systems and maximizing their value for customers.

The Cardiac Rhythm Management module enables virtual placement of pacemakers and defibrillators. Any change in the patient's heart rate during the simulation sounds an alarm so trainees can learn to provide immediate treatment. For the first time, trainees have the ability to train on canulating the coronary sinus, placing a lead and perform electrical measurements in a virtual and safe environment.

The Cerebral Intervention module features complete neurovasculature and a biplane x-ray system, making it the perfect platform for learning how to deliver intracranial coils and stents. Simbionix's CEO, Gary Zamler, explains; "This module gives neuro-interventionists the opportunity to handle complications, such as a perforated aneurysm, in our unique simulation environment, rather than in the OR."

Mr. Zamler continues: "We at Simbionix are proud of these two new modules and their potential contribution to the quality of medical practice."

Dr Thomas Masaryk, Chairman and Fellowship Director at The Cleveland Clinic Neuroradiology, is also excited about the new module: "Historically one might say that I've been a "simulator skeptic." But, I was utterly amazed with what Simbionix has accomplished: a thoroughly impressive recreation of complex aneurysm coiling. As head of our ACGME fellowship with over twenty years of experience, I have no doubt that the cerebral intervention module will change the way we teach intracranial procedures. In the future I foresee a significant impact on case planning and decision making. Now trainees can gain experience with difficult cases before encountering these critical challenges in real life."

About Simbionix

Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.

Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures. http://www.simbionix.com

    Contact:

    Inbal Mazor
    VP Marketing
    Simbionix
    mailto:inbal@simbionix.com
   http://www.simbionix.com
    Tel: +1-216-229-2040

    Simulation to Advance Clinical Performance

'/>"/>
SOURCE Simbionix Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Gynecologists Get First Hands-On Experience With Simbionix LAP Mentor(TM)
2. Center for Healthcare Research & Transformation Releases Cover Michigan - a Report on Healthcare Coverage and Access
3. Pocket Reference Journals Releases Latest Edition of "All About Me" Leading Children's Immunization Journal for New Moms
4. APHA Releases Public Health Priorities for New Congress and Administration
5. Grocery Manufacturers Association Releases Science Policy Paper on Sodium and Salt
6. Pennsylvania Patient Safety Authority Releases December Advisory
7. RingingCedarsofRussia.org Releases Pine Nut Oil Research Showing That Digestive and Stomach Disorders Respond to Unique Super Food: Siberian Pine Nut Oil
8. CSC Announces New Releases of Enterprise Content Management Solutions for Life Sciences Industry
9. HIMSS Releases Health IT Blueprint for Obama Administration and Congress
10. The Adventures of Scooter McDoogal Releases Trilogy of Human Anatomy Comic Books
11. Americans United for Life Releases Eight New Model Legislation & Policy Guides: Twenty-Three Model Legislation & Policy Guides Now Available
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... (PRWEB) , ... February 17, 2017 , ... ... , drvallecillos.com , Beverly Hills plastic surgeon Dr. Glenn Vallecillos ... cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been centered around that ...
(Date:2/17/2017)... , ... February 17, 2017 , ... Smiles by Seese ... Center in Davidson, NC. Dr. Brian Seese leads the practice as a skilled and ... under one roof. Smiles by Seese serves patients of all ages with excellence in ...
(Date:2/17/2017)... ... February 17, 2017 , ... For the ... management solution to the exhibit floor for the 2017 HIMSS Conference & ... From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected at ...
(Date:2/17/2017)... ... 2017 , ... Qualis Health, one of the nation's leading ... DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs that are ... award categories, highlighting four of the organization’s current programs:, , ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended CHI's ... facets of clinical trial planning and management. Pharmica discussed the importance of effective ... addition, attendees stopping by Pharmica’s booth were able to demo its cloud-based ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017  Noble Capital Markets ... ESSA Pharma Inc. (Nasdaq: EPIX ). The ... Kumar Raja , PhD. ESSA Pharmaceuticals ... castration resistant prostate cancer (CRPC). Its lead compound EPI-506, ... the amino-terminal domain of the androgen receptor, thereby has ...
(Date:2/16/2017)... 16, 2017 Research and Markets has ... Medical Device Technologies" report to their offering. ... Traditional medical ... general instruments, non-drug coated implantables, large endoscopes, needle based drug ... over the last two to three decades for the treatment ...
(Date:2/16/2017)... DaVita Inc. (NYSE: DVA ) today announced results ... Net income attributable to DaVita Inc. for the ... or $0.80 per share and $880 million, or $4.29 per ... DaVita Inc. for the quarter and year ended December 31, ... or $0.98 per share, and $789 million, or $3.85 per ...
Breaking Medicine Technology: